Unraveling the relationship between obesity, schizophrenia and cognition

Schizophrenia Research

Volumn 151, Issue 1-3, 2013, Pages 107-112

  Abdul Rashid, Nur Amirah ^a   Lim, Jeanette ^a   Lam, Max ^a   Chong, Siow Ann ^a   Keefe, Richard S E ^b   Lee, Jimmy ^a,c  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Body mass index; Gender; Indirect effects; Structural equation modeling

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; STRUCTURAL EQUATION MODELING;

BODY MASS INDEX; GENDER; INDIRECT EFFECTS; STRUCTURAL EQUATION MODELING;

ADULT; ANALYSIS OF VARIANCE; BODY MASS INDEX; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEUROPSYCHOLOGICAL TESTS; OBESITY; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84889081469     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.09.020     Document Type: Article

References (45)

1. Alosco M.L., Spitznagel M.B., Strain G., Devlin M., Cohen R., Paul R., Crosby R.D., Mitchell J.E., Gunstad J. Improved memory function two years after bariatric surgery. Obesity (Silver Spring) 2013, (in press). 10.1002/oby.20494.
2. Arbuckle J.L. AMOS, Version 21.0 2012, IBM SPSS, Chicago.
3. Axelrod B.N., Woodard J.L., Henry R.R. Analysis of an abbreviated form of the Wisconsin Card Sorting Test. Clin. Neuropsychol. 1992, 6:27-31.
4. Benton A.L., Hamsher K., Varney N.R., Spreen O. Contributions to Neuropsychological Assessment 1983, Oxford University Press, New York.
5. Chavance M., Escolano S., Romon M., Basdevant A., de Lauzon-Guillain B., Charles M.A. Latent variables and structural equation models for longitudinal relationships: an illustration in nutritional epidemiology. BMC Med. Res. Methodol. 2010, 10:37.
6. Citrome L., Vreeland B. Obesity and mental illness. Metabolic Effects of Psychotropic Drugs: Modern Trends in Pharmacopsychiatry 2009, 25-46. Karger, Basel. J. Thakore, B.E. Leonard (Eds.).
7. Cornblatt B.A., Risch N.J., Faris G., Friedman D., Erlenmeyer-Kimling L. The Continuous Performance Test, Identical Pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res. 1988, 26:223-238.
8. Amos Development Corporation User-defined estimand: multiple estimands Available at:, (Accessed 7 June 2013). http://amosdevelopment.com/video/user-defined-estimands/multiple-estimands/amos20/multiple-estimands-amos20.html.
9. Dahl A.K., Hassing L.B. Obesity and cognitive aging. Epidemiol. Rev. 2013, 35:22-32.
10. Elman I., Borsook D., Lukas S.E. Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology 2006, 31:2091-2120.
11. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured clinical interview for DSM-IV-TR axis I disorders, research version, non-patient edition. (SCID-I/NP) 2008, Biometrics Research, New York State Psychiatric Institute, New York.
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. (SCID-I/P) 2008, Biometrics Research, New York State Psychiatric Institute, New York.
13. Friedman J.I., Wallenstein S., Moshier E., Parrella M., White L., Bowler S., Gottlieb S., Harvey P.D., McGinn T.G., Flanagan L., Davis K.L. The effects of hypertension and body mass index on cognition in schizophrenia. Am. J. Psychiatry 2010, 167:1232-1239.
14. Goff D.C., Sullivan L.M., McEvoy J.P., Meyer J.M., Nasrallah H.A., Daumit G.L., Lamberti S., D'Agostino R.B., Stroup T.S., Davis S., Lieberman J.A. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr. Res. 2005, 80:45-53.
15. Gunstad J., Strain G., Devlin M.J., Wing R., Cohen R.A., Paul R.H., Crosby R.D., Mitchell J.E. Improved memory function 12weeks after bariatric surgery. Surg. Obes. Relat. Dis. 2011, 7:465-472.
16. Hermann S., Rohrmann S., Linseisen J., May A.M., Kunst A., Besson H., Romaguera D., Travier N., Tormo M.-J., Molina E., Dorronsoro M., Barricarte A., Rodríguez L., Crowe F.L., Khaw K.-T., Wareham N.J., van Boeckel P.G.A., Bueno-de-Mesquita H.B., Overvad K., Jakobsen M.U., Tjønneland A., Halkjær J., Agnoli C., Mattiello A., Tumino R., Masala G., Vineis P., Naska A., Orfanos P., Trichopoulou A., Kaaks R., Bergmann M.M., Steffen A., Van Guelpen B., Johansson I., Borgquist S., Manjer J., Braaten T., Fagherazzi G., Clavel-Chapelon F., Mouw T., Norat T., Riboli E., Rinaldi S., Slimani N., Peeters P.H.M. The association of education with body mass index and waist circumference in the EPIC-PANACEA study. BMC Public Health 2011, 11:169.
17. Jurdak N.A., Kanarek R.B. Potential consequences of obesity on cognitive behavior. Diet, Brain, Behavior: Practical Implications 2011, 133-152. CRC Press, Boca Raton, FL. R.B. Kanarek, H.R. Lieberman (Eds.).
18. Keefe R.S.E., Goldberg T.E., Harvey P.D., Gold J.M., Poe M.P., Coughenour L. The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr. Res. 2004, 68:283-297.
19. Keefe R.S.E., Sweeney J.A., Gu H., Hamer R.M., Perkins D.O., McEvoy J.P., Lieberman J.A. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am. J. Psychiatry 2007, 164:1061-1071.
20. Khera A., Vega G.L., Das S.R., Ayers C., McGuire D.K., Grundy S.M., de Lemos J.A. Sex differences in the relationship between C-reactive protein and body fat. J. Clin. Endocrinol. Metab. 2009, 94:3251-3258.
21. Lee J., Jiang J., Sim K., Tay J., Subramaniam M., Chong S.-A. Gender differences in Singaporean Chinese patients with schizophrenia. Asian J. Psychiatry 2011, 4:60-64.
22. Lee J., Nurjono M., Wong A., Salim A. Prevalence of metabolic syndrome among patients with schizophrenia in Singapore. Ann. Acad. Med. Singapore 2012, 41:457-462.
23. Lindenmayer J.P., Khan A., Kaushik S., Thanju A., Praveen R., Hoffman L., Cherath L., Valdez G., Wance D. Relationship between metabolic syndrome and cognition in patients with schizophrenia. Schizophr. Res. 2012, 142:171-176.
24. Loh F.-H., Khin L.-W., Saw S.-M., Lee J.J.M., Gu K. The age of menopause and the menopause transition in a multiracial population: a nation-wide Singapore study. Maturitas 2005, 52:169-180.
25. Lovejoy J.C. The menopause and obesity. Prim. Care 2003, 30:317-325.
26. MacCallum R.C., Wegener D.T., Uchino B.N., Fabrigar L.R. The problem of equivalent models in applications of covariance structure analysis. Psychol. Bull. 1993, 114:185-199.
27. McEvoy J.P., Meyer J.M., Goff D.C., Nasrallah H.A., Davis S.M., Sullivan L., Meltzer H.Y., Hsiao J., Stroup T.S., Lieberman J.A. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 2005, 80:19-32.
28. Meyer J.M., Nasrallah H.A., McEvoy J.P., Goff D.C., Davis S.M., Chakos M., Patel J.K., Keefe R.S.E., Stroup T.S., Lieberman J.A. The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr. Res. 2005, 80:9-18.
29. Ministry of Health National Health Survey 2010 (Available at), (Accessed 7 June 2013). http://www.moh.gov.sg/content/moh_web/home/Publications/Reports/2011/national_health_survey2010.html.
30. Nasrallah H.A. Linkage of cognitive impairments with metabolic disorders in schizophrenia. Am. J. Psychiatry 2010, 167:1155-1157.
31. Newcomer J.W. Antipsychotic medications: metabolic and cardiovascular risk. J. Clin. Psychiatry 2007, 68(Suppl. 4):8-13.
32. Preacher K.J., Hayes A.F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Methods 2008, 40:879-891.
33. Schreiber J.B., Nora A., Stage F.K., Barlow E.A., King J. Reporting structural equation modeling and confirmatory factor analysis results: a review. J. Educ. Res. 2006, 99:323-337.
34. Sherwin B.B. Estrogen and cognitive functioning in women. Endocr. Rev. 2003, 24:133-151.
35. Smith E., Hay P., Campbell L., Trollor J.N. A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obes. Rev. 2011, 12:740-755.
36. SPSS Inc. PASW Statistics for Windows, Version 18.0 2009, SPSS Inc., Chicago.
37. Swanson C.L., Gur R.C., Bilker W., Petty R.G., Gur R.E. Premorbid educational attainment in schizophrenia: association with symptoms, functioning, and neurobehavioral measures. Biol. Psychiatry 1998, 44:739-747.
38. Sweat V., Starr V., Bruehl H., Arentoft A., Tirsi A., Javier E., Convit A. C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation 2008, 31:198-207.
39. Takayanagi Y., Cascella N.G., Sawa A., Eaton W.W. Diabetes is associated with lower global cognitive function in schizophrenia. Schizophr. Res. 2012, 142:183-187.
40. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophr. Res. 2009, 110:1-23.
41. Tay Y.H., Nurjono M., Lee J. Increased Framingham 10-year CVD risk in Chinese patients with schizophrenia. Schizophr. Res. 2013, 147:187-192.
42. Ullman J.B. Structural equation modeling. Using Multivariate Statistics 2007, 676-780. Allyn and Bacon, Boston. Fifth ed. B.G. Tabachnick, L.S. Fidell (Eds.).
43. Wechsler D. Wechsler Adult Intelligence Scale-III 1997, The Psychological Corporation, San Antonio, TX.
44. World Health Organization WHO | Obesity and Overweight 2013, WHO, (Available at: http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 7 June 2013).
45. Yamada-Goto N., Katsuura G., Nakao K. Mental function and obesity. Functional Brain Mapping and the Endeavor to Understand the Working Brain 2013, InTech, New York. F. Signorelli (Ed.).